Get access

A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme

Authors

  • Shuji Inoue,

    1. Department of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan
    2. Global COE, “Cell Fate Regulation Research and Education Unit”, Kumamoto University, Kumamoto, Japan
    Search for more papers by this author
  • Miki Inoue,

    1. Department of Internal Medicine, Tokyo Hitachi Hospital, Bunkyo-Ku, Tokyo, Japan
    Search for more papers by this author
  • Sayoko Fujimura,

    1. Department of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan
    Search for more papers by this author
  • Ryuichi Nishinakamura

    Corresponding author
    1. Department of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan
    2. Global COE, “Cell Fate Regulation Research and Education Unit”, Kumamoto University, Kumamoto, Japan
    • Department of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, 2-2-1 Honjo, Kumamoto 860-0811, Japan
    Search for more papers by this author

Abstract

Sall1 is expressed in the metanephric mesenchyme in the developing kidney, and mice deficient in Sall1 show kidney agenesis or dysgenesis. Sall1 is also expressed elsewhere, including in the limb buds, anus, heart, and central nervous system. Dominant-negative mutations of Sall1 in mice and humans lead to developmental defects in these organs. Here, we generated a mouse line expressing tamoxifen-inducible Cre recombinase (CreERT2) under the control of the endogenous Sall1 promoter. Upon tamoxifen treatment, these mice showed genomic recombination in the tissues where endogenous Sall1 is expressed. When CreERT2 mice were crossed with the floxed Sall1 allele, tamoxifen administration during gestation led to a significant decrease in Sall1 expression and small kidneys at birth, suggesting that Sall1 functions were disrupted. Furthermore, Sall1 expression in the kidney was significantly reduced by neonatal tamoxifen treatment. The Sall1CreERT2 mouse is a valuable tool for in vivo time-dependent and region-specific knockout and overexpression studies. genesis 48:207–212, 2010. © 2010 Wiley-Liss, Inc.

Ancillary